{"id":40698,"date":"2021-04-15T11:16:26","date_gmt":"2021-04-15T11:16:26","guid":{"rendered":"https:\/\/www.gkseries.com\/blog\/?p=40698"},"modified":"2021-04-15T11:16:28","modified_gmt":"2021-04-15T11:16:28","slug":"dcgi-gives-nod-for-restricted-emergency-use-of-sputnik-v-in-india","status":"publish","type":"post","link":"https:\/\/www.gkseries.com\/blog\/dcgi-gives-nod-for-restricted-emergency-use-of-sputnik-v-in-india\/","title":{"rendered":"DCGI gives nod for restricted emergency use of Sputnik V in India"},"content":{"rendered":"\n<p>India&#8217;s drug regulator Drugs Controller General of India (DCGI) has granted permission for the restricted emergency use of Russian COVID-19 vaccine &#8221;Sputnik V&#8221; with certain conditions, paving the way for a third vaccine to be available in the country.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><a href=\"https:\/\/www.gkseries.com\/blog\/category\/daily-quiz\/\" target=\"_blank\" rel=\"noreferrer noopener\">Daily Current Affairs Quiz 2021<\/a><\/h2>\n\n\n\n<p>Sputnik V is the third vaccine to be made available in India after the Serum Institute of India\u2019s Covishield and Bharat Biotech\u2019s Covaxin.<\/p>\n\n\n\n<p>Sputnik V, developed by Russia\u2019s Gamaleya Research Institute of Epidemiology and Microbiology, claims to be one of the three vaccines in the world with efficacy of over 90%.<\/p>\n\n\n\n<p>the vaccine supplies for the global market will be produced by the Russian Direct Investment Fund (RDIF) international partners in India, Brazil, China, South Korea and other countries.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>India&#8217;s drug regulator Drugs Controller General of India (DCGI) has granted permission for the restricted emergency use of Russian COVID-19 vaccine &#8221;Sputnik V&#8221; with certain conditions, paving the way for a third vaccine to be available in the country. Daily Current Affairs Quiz 2021 Sputnik V is the third vaccine to be made available in [&hellip;]<\/p>\n","protected":false},"author":404,"featured_media":40699,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1403],"tags":[],"offerexpiration":[],"class_list":["post-40698","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-current-affairs-april-2021"],"_links":{"self":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/40698","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/users\/404"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/comments?post=40698"}],"version-history":[{"count":1,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/40698\/revisions"}],"predecessor-version":[{"id":40700,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/posts\/40698\/revisions\/40700"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/media\/40699"}],"wp:attachment":[{"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/media?parent=40698"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/categories?post=40698"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/tags?post=40698"},{"taxonomy":"offerexpiration","embeddable":true,"href":"https:\/\/www.gkseries.com\/blog\/wp-json\/wp\/v2\/offerexpiration?post=40698"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}